Alkahest, Inc. Alkahest, Inc.

alkahest.com

Alkahest is developing therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline -- key medical challenges of our generation. The company’s breakthrough research has demonstrated that factors in blood plasma of young mice are able to reverse brain deficits in normal aging and Alzheimer’s disease models in mice. Clinical studies are being conducted in patients with different types of dementia and other neurodegenerative diseases. Alkahest is a private company based in San Carlos, CA, with investors including Barcelona, Spain-based Grifols, a global healthcare company and leading producer of plasma therapies, also a collaboration and commercialization partner.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

THERMO FISHER SCIENTIFIC HIGHLIGHTS GROWING CAPACITY FOR BIOLOGICS, CELL AND GENE THERAPY PRODUCTION DURING BIO 2020

PR Newswire | June 08, 2020

news image

For biopharma companies seeking increased development and manufacturing capacity for vaccines and therapies, including new COVID-19-related programs, Thermo Fisher Scientific provided highlights of its new capabilities during the BIO International Convention, June 8-12, now a virtual event at www.bio.org/events/bio-digital."We can now provide an uninterrupted path from development to commercialization for biopharma companies, small to large, in geographies worldwide and across vaccine...

Read More

Research

LUNAPHORE AND INDICA LABS ANNOUNCE PARTNERSHIP TO PROVIDE COMPLETE TECHNOLOGY SOLUTION FOR SPATIAL BIOLOGY AND IMAGE ANALYSIS

Indica Labs | May 13, 2022

news image

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Indica Labs, a leading provider of computational pathology software and services, today announced a partnership to co-market an end-to-end solution that combines Lunaphore's flagship COMET™ spatial biology platform and Indica's HALO® and HALO AI™ digital pathology image analysis software. Lunaphore's COMET™ platform provides superior m...

Read More

Cell and Gene Therapy, AI

BENEVOLENTAI PROGRESSES BEN-34712 FOR THE POTENTIAL TREATMENT OF ALS INTO IND-ENABLING STUDIES

Businesswire | June 05, 2023

news image

BenevolentAI, a leader in the development of cutting-edge AI that accelerates biopharma discovery, announces the successful delivery of its pre-clinical candidate for the potential treatment of amyotrophic lateral sclerosis (ALS), BEN-34712. BEN-34712 is an oral, potent and selective brain penetrant RARɑβ (retinoic acid receptor alpha beta) biased agonist and will now enter investigational new drug (IND)-enabling studies. Impaired retinoic acid signalling has bee...

Read More

TWINSTRAND BIOSCIENCES LAUNCHES DUPLEX SEQUENCING TECHNOLOGY

BioSpace | February 25, 2020

news image

TwinStrand Biosciences™, a next-generation DNA sequencing technology company, today announced the launch of TwinStrand Duplex Sequencing™ Technology kits at the annual Advances in Genome Biology and Technology (AGBT) General Meeting in Marco Island, Florida. At launch, the company will offer their platform technology for two research applications: detection of minimal residual disease in acute myeloid leukemia patients (AML MRD) and a multi-species genetic toxicology assay for rapid ...

Read More
news image

THERMO FISHER SCIENTIFIC HIGHLIGHTS GROWING CAPACITY FOR BIOLOGICS, CELL AND GENE THERAPY PRODUCTION DURING BIO 2020

PR Newswire | June 08, 2020

For biopharma companies seeking increased development and manufacturing capacity for vaccines and therapies, including new COVID-19-related programs, Thermo Fisher Scientific provided highlights of its new capabilities during the BIO International Convention, June 8-12, now a virtual event at www.bio.org/events/bio-digital."We can now provide an uninterrupted path from development to commercialization for biopharma companies, small to large, in geographies worldwide and across vaccine...

Read More
news image

Research

LUNAPHORE AND INDICA LABS ANNOUNCE PARTNERSHIP TO PROVIDE COMPLETE TECHNOLOGY SOLUTION FOR SPATIAL BIOLOGY AND IMAGE ANALYSIS

Indica Labs | May 13, 2022

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Indica Labs, a leading provider of computational pathology software and services, today announced a partnership to co-market an end-to-end solution that combines Lunaphore's flagship COMET™ spatial biology platform and Indica's HALO® and HALO AI™ digital pathology image analysis software. Lunaphore's COMET™ platform provides superior m...

Read More
news image

Cell and Gene Therapy, AI

BENEVOLENTAI PROGRESSES BEN-34712 FOR THE POTENTIAL TREATMENT OF ALS INTO IND-ENABLING STUDIES

Businesswire | June 05, 2023

BenevolentAI, a leader in the development of cutting-edge AI that accelerates biopharma discovery, announces the successful delivery of its pre-clinical candidate for the potential treatment of amyotrophic lateral sclerosis (ALS), BEN-34712. BEN-34712 is an oral, potent and selective brain penetrant RARɑβ (retinoic acid receptor alpha beta) biased agonist and will now enter investigational new drug (IND)-enabling studies. Impaired retinoic acid signalling has bee...

Read More
news image

TWINSTRAND BIOSCIENCES LAUNCHES DUPLEX SEQUENCING TECHNOLOGY

BioSpace | February 25, 2020

TwinStrand Biosciences™, a next-generation DNA sequencing technology company, today announced the launch of TwinStrand Duplex Sequencing™ Technology kits at the annual Advances in Genome Biology and Technology (AGBT) General Meeting in Marco Island, Florida. At launch, the company will offer their platform technology for two research applications: detection of minimal residual disease in acute myeloid leukemia patients (AML MRD) and a multi-species genetic toxicology assay for rapid ...

Read More

Resources

resource image

Industry Outlook

Biopharmaceutical Sector

Whitepaper

resource image

Cell and Gene Therapy

VIA Thaw™ automated dry thawer

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us